Invention Grant
- Patent Title: Cysteine protease
-
Application No.: US16879324Application Date: 2020-05-20
-
Publication No.: US11214784B2Publication Date: 2022-01-04
- Inventor: Christian Kjellman , Sofia Jarnum , Emma Nordahl
- Applicant: Hansa BioPharma AB
- Applicant Address: SE Lund
- Assignee: Hansa BioPharma AB
- Current Assignee: Hansa BioPharma AB
- Current Assignee Address: SE Lund
- Agency: Norton Rose Fulbright US LLP
- Priority: GB1502306 20150212
- Main IPC: A61K38/48
- IPC: A61K38/48 ; C12N9/52 ; C12N9/54 ; A61K38/00
Abstract:
The present invention relates to a novel polypeptide which displays IgG cysteine protease activity, and in vivo and ex vivo uses thereof. Uses of the polypeptide include methods for the prevention or treatment of diseases and conditions mediated by IgG, and methods for the analysis of IgG.
Public/Granted literature
- US20200283749A1 CYSTEINE PROTEASE Public/Granted day:2020-09-10
Information query
IPC分类:
